The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 61 , ISSUE 1 ( January-March, 2019 ) > List of Articles

Original Article

Demographic Profile, Smoking Cessation Interventions and Continuous Abstinence of Tobacco Users at Two Years

Raj Kumar, Shyam Kanhaiya Saroj, Manoj Kumar, Gopal C. Mahakud

Keywords : Tobacco cessation, Counselling, Pharmacotherapy, Abstinence rate

Citation Information : Kumar R, Saroj SK, Kumar M, Mahakud GC. Demographic Profile, Smoking Cessation Interventions and Continuous Abstinence of Tobacco Users at Two Years. Indian J Chest Dis Allied Sci 2019; 61 (1):31-37.

DOI: 10.5005/ijcdas-61-1-31

License: CC BY-NC 4.0

Published Online: 18-11-2022

Copyright Statement:  Copyright © 2019; The Author(s).


Abstract

Background: Vallabhbhai Patel Chest Institute, Delhi is providing tobacco cessation services since November 2001. Since then many tobacco users visited and availed these services. Objectives: This study was undertaken to assess the demographic profile and the abstinence rate of the tobacco users at two years, outcomes of a cessation clinic in India, its success rate, type of people enrolling for cessation services, type of tobacco and tobacco dependence. Methods: Tobacco cessation counselling and pharmacotherapy, if required, were provided to tobacco users registered at Tobacco Cessation Centre (TCC) of our Institute from November 2001 to December 2016. During counselling, demographic details and details of tobacco use were obtained. Brief intervention strategies of RAJKUMAR (R=Reaching to the subject, A=assess the stage of change, J=Judge the severity, K=Know the risky situations, U=Use coping skills, M=Medication required or not, A=Arrange follow up, R=Re-evaluation) were applied. Results: Out of a total 7231 registered tobacco users, 7010 (97%) were males with a mean age (±SD) of 42.2 (±14.9) years. Most of the subjects (81%) belonged to urban areas. Majority of them (58.8%) were smokers, with 21.7% severly dependent on tobacco. Overall, continuous abstinence rate was observed to be 53.7%, 47.7%, 38.7%, 31%, 29.5%, 28.8% and 24% at 1, 3, 6, 9, 12, 18 and 24 months, respectively. In non-pharmacotherapy group, continuous abstinence rate for the same period was 55.3%, 46.1%, 35%, 23.9%, 22.4%, 22% and 18.3%, respectively, while in the pharmacotherapy group it was 51.1%, 50.1%, 44.5%, 41.8%, 40.3%, 36.4%, and 32.3%, respectively. Conclusions: Present study showed that tobacco users in the age group of 30-40 years are more interested to quit tobacco. A significant number of tobacco users (24%) continuously abstain from using tobacco for more than two years. Our results suggest that those using pharmacotherapy for tobacco cessation achieve a higher rate of abstinence. A 10-minute behavioural counselling was also found to be effective in reducing and/or quitting tobacco use.


PDF Share
  1. Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, et al. Smoking prevalence and cigarette consumption in 187 Countries, 1980-2012. JAMA 2014;311: 183–92.
  2. Benowitz N. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Phar Ther 2008;83:531–41.
  3. World Health Organization. Tobacco free initiatives-About smoking cessation. Available at URL: http://www.who.int/tobacco/research/cessation/about/en. Accessed on August 29, 2016.
  4. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2013. Geneva: World Health Organization; 2013. Available at URL: http://www.who.int/tobacco/globalreport/2013/en/. Accessed on August 29, 2016.
  5. World Health Organization. WHO worldwide current situation of national quit-line services. In: Developing and Improving National Toll-free Tobacco Quit Line services- A World Health Organization manual. Geneva: World Health Organization; 2011:12–14.
  6. GATS. GATS India Report 2016-2017. Mumbai: Tata Institute of Social Sciences (TISS) and New Delhi: Ministry of Health and Family Welfare, 2016.
  7. US Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006: p.709.
  8. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002;2:372–7.
  9. Foulds J, Ramstrom L, Burke M, Fagerstrom K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 2003;12:349–59.
  10. Centers for Disease Control and Prevention. Health Effects of Cigarette Smoking. Available at URL: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/index.htm. Accessed on August 23, 2016.
  11. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86:1119–27.
  12. Varghese C, Kaur J, Desai NG, Murthy P, Malhotra S, Subbakrishna DK, et al. Initiating tobacco cessation services in India: challenges and opportunities. WHO-SEAJ of Public Health 2012;1:159–68.
  13. Centers for Disease Control and Prevention. Tobacco information and prevention source (TIPS). Available at URL: https://www.cdc.gov/tobacco/data_statistics/mmwrs/bytopic/global_data/archive/index.htm. Accessed on August 29, 2016.
  14. Murthy P, Saddichha S. Tobacco cessation services in India: recent developments and the need for expansion. Indian J Cancer 2010;47(Suppl.):69–74.
  15. Sorensen G, Gupta PC, Pednekar MS. Social disparities in tobacco use in Mumbai, India: the roles of occupation, education, and gender. Am J Public Health 2005;95:1003–8.
  16. Kumar R, Kushwah AK, Prakash S, Vijayan VK. A study of tobacco consumption among college students of University of Delhi, Delhi, India. Indian J Prev Soc Med 2010;41:198–202.
  17. Burling TA, Ziff DC. Tobacco smoking: a comparison between alcohol and drug abuse inpatients. J Addict Behav 1988;13:185–90.
  18. Miller NS, Gold MS. Comorbid cigarette and alcohol addiction: epidemiology and treatment. J Addict Dis 1998;17:55–66.
  19. Marks JL, Hill EM, Pomerleau CS, Mudd SA, Blow FC. Nicotine dependence and withdrawal in alcoholic and nonalcoholic eversmokers. J Subst Abuse Treat 1997;14:521–7.
  20. Galanti M, Holm Ivarsson B, Helgason A, Gilljam H. Smoking cessation: gender on the agenda. Drugs: Education, Prevention and Policy 2002;9:71–84.
  21. Alpert HR, Connolly GN, Biener L. A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tob Control 2013;22:32–37.
  22. US Surgeon General. The health benefits of smoking cessation in a report of the Surgeon General. Rockville: U.S. Department of Health and Human Services; 1990.
  23. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville: U.S Department of Health and Human Service. Public Health Service; 2008.
  24. Kumar R, Kushwah AS, Mahakud GC, Prakash S, Vijayan VK. Smoking cessation interventions and continuous abstinence rate at one year. Indian J Chest Dis Allied Sci 2007;49:201–7.
  25. Kennedy DT, Giles JT, Chang ZG, Small RE, Edwards JH. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharmaceut Assoc 2002;42:51–56.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.